Ferrous Gluconate Anhydrous

Summary

Ferrous Gluconate Anhydrous (CHEMBL3991443) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL3991443
Name	Ferrous Gluconate Anhydrous
Type	Small molecule
Max phase	4

Also known as: Ferrous gluconate anhydrous, Iron(ii) gluconate, anhydrous

Parent form; salt/anhydrous children: CHEMBL3833303

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indications (0 at ChEMBL trial phase 4).

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).